-
R&D News | Sinopeg’s Key Excipient for Nucleic Acid Drug Delivery, DSPE-PEG-MAL, Reaches Another Milestone – CDE Filing Completed!
June 8,2026.
Recently, Sinopeg’s LNP lipid excipient product, DSPE-PEG-MAL(NH4+)-2K, has successfully completed pharmaceutical excipient filing with the Center for Drug Evaluation (CDE) of the National Medical Pro...
View More
-
Sinopeg Expands Portfolio: mPEG-PLA Passes CDE Filing
June 24,2026.
Recently, Sinopeg has achieved another significant milestone in the field of drug delivery carriers. Methoxy polyethylene glycol polylactide (mPEG-PLA-(2+2)K) has successfully passed the review by the...
View More